BOSTON SCIENTIFIC CORP (BSX) Stock Analyst Ratings
NYSE:BSX • US1011371077
74.12 USD
+0.65 (+0.88%)
At close: Feb 12, 2026
74 USD
-0.12 (-0.16%)
After Hours: 2/12/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 86% to BSX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 125.5. This target is 69.32% above the current price.
- BSX was analyzed by 40 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BSX.
- In the previous month the buy percentage consensus was at a similar level.
- BSX was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-09 | BTIG | Reiterate | Buy -> Buy |
| 2026-02-05 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-05 | UBS | Maintains | Buy -> Buy |
| 2026-02-05 | Needham | Maintains | Buy -> Buy |
| 2026-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-05 | Stifel | Maintains | Buy -> Buy |
| 2026-02-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-05 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-05 | Baird | Maintains | Outperform -> Outperform |
| 2026-02-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-05 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-04 | BTIG | Maintains | Buy -> Buy |
| 2026-02-03 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-21 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-23 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-22 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-17 | Needham | Reiterate | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
BOSTON SCIENTIFIC CORP / BSX FAQ
What is the average price target for BOSTON SCIENTIFIC CORP (BSX) stock?
40 analysts have analysed BSX and the average price target is 125.5 USD. This implies a price increase of 69.32% is expected in the next year compared to the current price of 74.12.
What is the consensus rating for BSX stock?
The consensus rating for BOSTON SCIENTIFIC CORP (BSX) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.